I continue to believe that the Z script numbers will get a significant boost from the promotional activities associated with the launch of the Z OTC, when that starts which should hopefully be starting within 3 months or so from now. Given the continuing large market for branded PIP medicine, and with increased Z visibility from the promotional launch of the OTC product, SNTS should get an opportunity to grow their share of the script market.